See every side of every news story
Published loading...Updated

Chocolate Compound Drug Reportedly Beats Tamiflu

HEBREW UNIVERSITY OF JERUSALEM, ISRAEL, AUG 6 – The new Theobromine-Arainosine drug combo targets a viral ion channel and neutralizes drug-resistant flu strains, offering a potential alternative to Tamiflu, researchers said.

  • Researchers at Hebrew University of Jerusalem published on August 4, 2025, a drug combo including a chocolate compound that outperforms Tamiflu against flu strains.
  • The team developed this treatment due to the increasing ineffectiveness of Tamiflu as influenza viruses mutate and resist existing drugs.
  • Theobromine and Arainosine block the M2 ion channel, a viral feature vital for replication, and the combo reduced viral RNA in lungs by over 75% in tests.
  • The treatment reduced viral RNA levels by 15,717-fold, significantly outperforming Tamiflu’s 3,077-fold reduction, and Prof. Isaiah Arkin emphasized that this represents more than simply an improved flu medication.
  • ViroBlock, a Hebrew University startup, is advancing this therapy toward human trials, indicating potential for broader antiviral applications beyond influenza.
Insights by Ground AI
Does this summary seem wrong?

13 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Monday, August 4, 2025.
Sources are mostly out of (0)